Salix, Cedars-Sinai Partner on Gut Microbiome–Related GI Treatments

Salix Pharmaceuticals said today it will partner with Cedars-Sinai Medical Center to discover new treatments for gastrointestinal (GI) disorders related to conditions of the gut microbiome, through a collaboration whose value was not disclosed.Salix, a wholly-owned subsidiary of Bausch Health—which changed its name from Valeant Pharmaceuticals on July 16—said it retains the option to acquire any therapeutic discovered through the research. Salix and Cedars-Sinai Medical Center plan t